Home » Newsletters » BioWorld Science

BioWorld Science

April 8, 2010

View Archived Issues

Swiss scientists describe novel anticancer agents

Sekmed discloses new vaccine adjuvants

Galapagos identifies novel androgen receptor ligands

SPARC staining predicts survival in rituximab-treated patients with ABC-type DLBCL

Two-year data reported on deferasirox in beta-thalassemia patients with cardiac siderosis

Quinapril and lipoic acid show benefit in metabolic syndrome

Preclinical data disclosed on discovery of novel CCK receptor antagonist JNJ-26273364

Amgen identifies novel CXCR3 antagonists for inflammatory conditions

Preclinical studies show involvement of galectin-1 in healing after acute myocardial infarction

Merck & Co. discloses new glucagon receptor antagonists

Bristol-Myers Squibb discovers new NS5B inhibitors

FDA grants fast track designation to Genta's tesetaxel for advanced gastric cancer

Lundbeck advances new agent Lu-AE-04621 to phase I for Parkinson's disease

FDA approves TachoSil surgical patch as adjunct to hemostasis in cardiovascular surgery

Allergan and Serenity Pharmaceuticals to collaborate on development Ser-120 for nocturia

Davunetide receives FDA fast track status for progressive supranuclear palsy

Bellus Health begins phase I trial of NRM-8499 for Alzheimer's disease

Living Cell Technologies' phase I/IIa Diabecell trial in type 1 diabetes meets endpoints

Recordati signs marketing agreement with Esteve for pitavastatin

Halozyme Therapeutics strengthens commercial supply agreements for rHuPH20

Multiple Myeloma Research Consortium initiates phase Ib/II Treanda trial in multiple myeloma

NeurogesX launches capsaicin patch for postherpetic neuralgia

Mologen receives funds to develop MIDGE-based DNA vaccine for hepatitis B

Phase II trial of ranibizumab in diabetic macular edema commences enrollment

MicuRx, Cumencor and Pfizer partner to develop antibiotics for multidrug-resistant tuberculosis

RXi and TransDerm form dermatology research collaboration

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 17, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 17, 2025.
CTAD 2025: Diagnosing semaglutide’s failure in Alzheimer’s trials
BioWorld
A little over a week after announcing that the Evoke and Evoke+ studies failed to show that oral semaglutide could slow cognition decline in patients with...
ABS-1230 controls seizures in KCNT1-driven severe epilepsy
BioWorld Science
Mutations in the KCNT1 gene produce gain-of-function effects that lead to overactivation of the potassium channel and consequent disruption of normal neuronal...
Apollo’s APL-4098 shows potent antileukemic effects
BioWorld Science
Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.